In cell lines derived from solid tumors (colon and gastric cancers), BECN1 ablation drastically decreases OXPHOS and lipid degradation and shifts cellular metabolism towards aerobic glycolysis, with increases in glucose uptake and lactate production [86,87]. The gene discussed is BECN1; the disease is gastric cancer.